Spark Therapeutics buy Quitte
Start price
12.12.17
/
50%
€41.29
Target price
01.02.18
€50.51
Performance (%)
22.74%
End price
01.02.18
€50.68
Summary
This prediction ended on 01.02.18 with a price of €50.68. The prediction had a final performance of 22.74%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Spark Therapeutics | - | - | - | - |
| iShares Core DAX® | -0,39 % | -1,79 % | 5,61 % | 55,04 % |
| iShares Nasdaq 100 | -2,40 % | 0,85 % | 36,02 % | 91,18 % |
| iShares Nikkei 225® | -0,82 % | 8,95 % | 67,62 % | 85,35 % |
| iShares S&P 500 | -1,05 % | -0,08 % | 24,99 % | 67,53 % |
Comments by Quitte for this prediction
In the thread Spark Therapeutics diskutieren
Lux am Ende des Tunnels
Luxturna hat den Priority Review-Status
der 12. Januar dürfte entscheidend sein
ich denke, es gibt Licht am Ende des Tunnels